0001209191-21-007724.txt : 20210204 0001209191-21-007724.hdr.sgml : 20210204 20210204161915 ACCESSION NUMBER: 0001209191-21-007724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210204 DATE AS OF CHANGE: 20210204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ahmadzai David CENTRAL INDEX KEY: 0001813060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12537 FILM NUMBER: 21591407 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC. CENTRAL INDEX KEY: 0000708818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 952888568 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 BUSINESS PHONE: 404-467-1500 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20100804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-03 0 0000708818 NEXTGEN HEALTHCARE, INC. NXGN 0001813060 Ahmadzai David 3525 PIEDMONT RD., NE BUILDING 6, SUITE 700 ATLANTA GA 30305 0 1 0 0 Chief Accounting Officer Common Stock 2021-02-03 4 M 0 3250 16.37 A 36952 D Common Stock 2021-02-03 4 M 0 1500 16.64 A 38452 D Common Stock 2021-02-03 4 M 0 3000 16.83 A 41452 D Common Stock 2021-02-03 4 S 0 10446 19.6122 D 31006 D Non-Qualified Stock option (right to buy) 16.37 2021-02-03 4 M 0 3250 0.00 D 2025-06-13 Common Stock 3250 3250 D Non-Qualified Stock option (right to buy) 16.64 2021-02-03 4 M 0 1500 0.00 D 2023-05-22 Common Stock 1500 0 D Non-Qualified Stock option (right to buy) 16.83 2021-02-03 4 M 0 3000 0.00 D 2026-06-01 Common Stock 3000 6000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.5801 to $19.67, inclusive. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request. Options exercised vested on June 13, 2020. Remaining options reported in column 9 will vest on June 13, 2021. Options exercised vested on May 22, 2020. Options exercised vested on June 1, 2020. Remaining options reported in column 9 will vest on June 1, 2021 and June 1, 2022. Jeffrey D. Linton, Attorney-in-Fact for David Ahmadzai 2021-02-04